CARCINOMA, RENAL CELL
Clinical trials for CARCINOMA, RENAL CELL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, RENAL CELL trials appear
Sign up with your email to follow new studies for CARCINOMA, RENAL CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Real-World data shows promise for kidney cancer combo therapy
Disease control CompletedThis study followed 105 people with advanced kidney cancer to see how well avelumab plus axitinib works as their first treatment in real-life settings. Researchers measured survival rates and side effects over 12 months. The goal was to understand the treatment's effectiveness ou…
Matched conditions: CARCINOMA, RENAL CELL
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated May 16, 2026 23:50 UTC
-
New drug combo shows promise for tough cancers
Disease control CompletedThis early-stage study tested a combination of two drugs, axitinib and everolimus, in 19 people with advanced solid tumors, especially kidney cancer. The main goal was to find the safest dose and identify side effects. Participants had already tried or could not use standard trea…
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE1 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated May 16, 2026 23:36 UTC
-
Immunotherapy combo before kidney removal shows promise in small trial
Disease control CompletedThis early-stage study tested whether giving two immunotherapy drugs (spartalizumab and canakinumab) before surgery for localized kidney cancer is safe and practical. Seventeen adults with clear cell renal cell carcinoma received the drugs before their scheduled kidney removal. T…
Matched conditions: CARCINOMA, RENAL CELL
Phase: EARLY_PHASE1 • Sponsor: Columbia University • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New test could help doctors pick the right cancer therapy faster
Knowledge-focused CompletedThis study tested a new method called the mass response biomarker to see if it can predict how well a cancer patient will respond to specific treatments. Researchers collected tumor cells from 72 adults with various cancers using fluid samples or tissue biopsies. The goal was to …
Matched conditions: CARCINOMA, RENAL CELL
Sponsor: Travera Inc • Aim: Knowledge-focused
Last updated May 16, 2026 23:51 UTC